Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis
- PMID: 21768401
- PMCID: PMC3202165
- DOI: 10.1093/aje/kwr172
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis
Abstract
The association between physiologic levels of sex hormones and QT-interval duration in humans was evaluated using data from 727 men enrolled in the Third National Health and Nutrition Examination Survey and 2,942 men and 1,885 postmenopausal women enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA). Testosterone, estradiol, and sex hormone-binding globulin levels were measured in serum and free testosterone was calculated from those values. QT interval was measured using a standard 12-lead electrocardiogram. In men from the Third National Health and Nutrition Survey, the multivariate adjusted differences in average QT-interval duration comparing the highest quartiles with the lowest quartiles of total testosterone and free testosterone were -8.5 ms (95% confidence interval (CI): -15.5, -1.4) and -8.0 ms (95% CI: -13.2, -2.8), respectively. The corresponding differences were -1.8 ms (95% CI: -3.8, -0.2), and -4.7 ms (95% CI: -6.7, -2.6), respectively, in men from MESA and -0.6 ms (95% CI: -3.0, 1.8) and 0.8 ms (95% CI: -1.6, 3.3), respectively, in postmenopausal women from MESA. Estradiol levels were not associated with QT-interval duration in men, but there was a marginally significant positive association in postmenopausal women. The findings suggest that testosterone levels may explain differences in QT-interval duration between men and women and could be a contributor to population variability in QT-interval duration among men.
Comment in
-
Invited commentary: sex-steroid hormones and QT-interval duration.Am J Epidemiol. 2011 Aug 15;174(4):412-5. doi: 10.1093/aje/kwr170. Epub 2011 Jul 18. Am J Epidemiol. 2011. PMID: 21768402
-
Re: "Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the Third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis".Am J Epidemiol. 2011 Dec 15;174(12):1423. doi: 10.1093/aje/kwr381. Epub 2011 Nov 15. Am J Epidemiol. 2011. PMID: 22085627 No abstract available.
References
-
- Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8(7):690–695. - PubMed
-
- Drici MD, Knollmann BC, Wang WX, et al. Cardiac actions of erythromycin: influence of female sex. JAMA. 1998;280(20):1774–1776. - PubMed
-
- Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation. 1996;94(10):2535–2541. - PubMed
-
- Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270(21):2590–2597. - PubMed
-
- Bai CX, Kurokawa J, Tamagawa M, et al. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation. 2005;112(12):1701–1710. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
